chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Did not meet age requirement
Age: 65.0
Sex: M
Vaccine: COVID19-2
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Error: Dose in Series Given Too Early-
Age: 11.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Error: Wrong Age for Vaccine Given-
Age: 50.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Error: Wrong Vaccine Formulation (ex. Prevnar 13 v. Prevnar 23)-
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Pain in extremity
Clinical narrative: Narrative:  08/25/2021 COVID vaccine dose #1-Patient developed left deltoid pain after vaccination, pain resolved about 8-9 weeks later 09/15/2021 COVID vaccine dose #2-Patient developed right arm pain after vaccination to right arm, pain resolved about 8-9 weeks later 05/05/2022 COVID vaccine dose #3-Patient developed stabbing pain, the pain on his left arm has been slowly increasing. 11/07/2022 At PCP visit, pt reports the pain is 2/10 intensity but increases when he lays on it or when pressure is applied to 8/10 intensity. Pain decreases a few minutes after pressure is removed. Provider ordered gabapentin to treat pain.
Age: 79.0
Sex: M
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, Dyspnoea
Clinical narrative: Narrative:  A 79yo male with PMH of multiple medical problems which included, NSTEMI, HTN, CAD, BPH, Cervical Stenosis, Obesity BMI 30+, Cervical Radiculopathy, OA, Recurrent Major Depression, PTSD, CKD stage III, Persistent Protein Urea due to Type II DM, Recurrent Angina post PTCA and Hypercholesterolemia. On September 18, 2022, attending physician reported the patient had an acute respiratory failure observed on September 16, 2022, possibly caused by PF- Pfizer Covid - 19 Booster vaccine-(12y and up). received on September 14, 2022. The administering RN documented, "He was provided with all required information, fact sheets regarding the vaccine and denied any prior severe reaction to the vaccine, its components or any vaccine or injectable therapy." The patient was admitted to Medicine and per the Attending Physician's note received Life Sustaining Treatment, had a Pulse Ox of 85% in the ED which improved to 94% after being placed on 2L nasal cannula. It was also documented the patient reported "he developed SOB two days ago after he received his 5th covid vaccine".
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, COVID-19, COVID-19 pneumonia, Cough, Hypoxia
Clinical narrative: Narrative:  Patient received two doses of COVID 19 vaccine in Mar/Apr 2021. The patient tested positive for COVID 19 on 23 September 2022. The patient presented to the ED with weakness, cough, and post-nasal drip. The patient was admitted with COVID pneumonia, sepsis, and hypoxia. The patient was treated with dexamethasone and remdesivir. The patient was discharged on 27 October with possible post covid syndrome. Reported per EUA.
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Sepsis, Upper-airway cough syndrome
Clinical narrative: Narrative:  Patient received two doses of COVID 19 vaccine in Mar/Apr 2021. The patient tested positive for COVID 19 on 23 September 2022. The patient presented to the ED with weakness, cough, and post-nasal drip. The patient was admitted with COVID pneumonia, sepsis, and hypoxia. The patient was treated with dexamethasone and remdesivir. The patient was discharged on 27 October with possible post covid syndrome. Reported per EUA.
Age: 97.0
Sex: M
Vaccine: VARZOS
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Erythema multiforme, Pruritus, Rash, Urticaria
Clinical narrative: SkinRash, ErythemaMultiform & UrticariaPruritus Narrative:
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Headache, Myalgia
Clinical narrative: Headache, Myalgia & Diarrhea Narrative:
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Headache, Myalgia, Sedation
Clinical narrative: Headache, Sedation, Myalgia, Arthralgia,  CHILLS Narrative:  Employee was instructed to contact PCP office for further care
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Chills
Clinical narrative: chills Narrative:
Age: 33.0
Sex: F
Vaccine: COVID19-2
Symptoms: Hypoaesthesia, Rash
Clinical narrative: SkinRash  numbness hands and feet
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: SkinRash REACCURING Narrative:
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Myalgia, Pyrexia
Clinical narrative: Myalgia, Arthralgia, Fever, fatigue Narrative:
Age: 59.0
Sex: M
Vaccine: COVID19-2
Symptoms: Injection site pain, Myalgia, Pyrexia
Clinical narrative: Myalgia, Fever, soreness at injection site Narrative:
Age: 50.0
Sex: F
Vaccine: COVID19-2
Symptoms: Erythema, Myalgia
Clinical narrative: Myalgia ERYTHEMA OF ARM Narrative:
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Condition aggravated, Headache, Impaired work ability, Myalgia
Clinical narrative: Headache, Myalgia, low back pain exacerbation, body aches, missed 3 days of work Narrative:
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Headache, Myalgia, low back pain exacerbation, body aches, missed 3 days of work Narrative:
Age: 57.0
Sex: F
Vaccine: COVID19-2
Symptoms: Cough, Headache, Pyrexia, Wheezing
Clinical narrative: Headache, Fever & CoughWheeze Narrative:
Age: 41.0
Sex: U
Vaccine: COVID19-2
Symptoms: Headache, Myalgia, Nausea, Vomiting
Clinical narrative: Headache, Myalgia & NauseaVomiting Narrative:
Age: 72.0
Sex: F
Vaccine: FLU4
Symptoms: Underdose, Wrong product administered
Clinical narrative: Patient received regular adult dose rather than high dose flu vaccine
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Myalgia, Pyrexia
Clinical narrative: Myalgia, Arthralgia, Fever, fatigue Narrative:
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Narrative:
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Angiogram pulmonary abnormal, Anticoagulant therapy, Atrial fibrillation, Atrial thrombosis
Clinical narrative: Narrative:  Patient called the Clinical Call Center to report he is on his 4th day of cough and congestion. Patient reports having severe shortness of breath with cough frequently. Patient reports productive cough with green sputum x 4 days, temperature normal but cannot remember the exact number, sore throat, nasal congestion, and headache. He reports testing negative for COVID-19 with home kit yesterday. He states that he has been taking Mucinex, Nebulizer treatments, and hydrating well and nothing is helping. He denies sob at rest, confusion, cp, vision changes, body aches. Patient advised to report to ED for evaluation. In ED, O2 sats in the low 90s at one point. HR was up to 121, pt received Lopressor (IV, 5mg, x2) w/ subsequent HR in low 100s. WBC 11.8K, Hgb 16.8. CMP largely unremarkable. Troponin negative. BNP 191. Covid PCR positive. EKG: Heart rate 121, A. fib, no ST elevation or depressions, occasional PVCs noted. CTA chest showing no evidence of PE, there is evidence of thrombus in left atrium, groundglass opacities in bilateral lower lobes and right upper lobe, nonobstructive nephrolithiasis less than 1 cm. Patient started on heparin drip. Patient also given morphine, Zofran, ketorolac. He received 3 days of IV Ceftriaxone and was de-escalated to Augmentin 875 mg BID X 2 more days. The patient was also treated for acute respiratory failure due to acute bacterial pneumonia. The patient did not require supplemental oxygen. He did not require any further care due to COVID-19 pneumonia. Pt admitted from 11/11/22 to 11/15/22.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Bacteriuria, Brain natriuretic peptide increased, COVID-19, COVID-19 pneumonia, Dyspnoea
Clinical narrative: Narrative:  Patient called the Clinical Call Center to report he is on his 4th day of cough and congestion. Patient reports having severe shortness of breath with cough frequently. Patient reports productive cough with green sputum x 4 days, temperature normal but cannot remember the exact number, sore throat, nasal congestion, and headache. He reports testing negative for COVID-19 with home kit yesterday. He states that he has been taking Mucinex, Nebulizer treatments, and hydrating well and nothing is helping. He denies sob at rest, confusion, cp, vision changes, body aches. Patient advised to report to ED for evaluation. In ED, O2 sats in the low 90s at one point. HR was up to 121, pt received Lopressor (IV, 5mg, x2) w/ subsequent HR in low 100s. WBC 11.8K, Hgb 16.8. CMP largely unremarkable. Troponin negative. BNP 191. Covid PCR positive. EKG: Heart rate 121, A. fib, no ST elevation or depressions, occasional PVCs noted. CTA chest showing no evidence of PE, there is evidence of thrombus in left atrium, groundglass opacities in bilateral lower lobes and right upper lobe, nonobstructive nephrolithiasis less than 1 cm. Patient started on heparin drip. Patient also given morphine, Zofran, ketorolac. He received 3 days of IV Ceftriaxone and was de-escalated to Augmentin 875 mg BID X 2 more days. The patient was also treated for acute respiratory failure due to acute bacterial pneumonia. The patient did not require supplemental oxygen. He did not require any further care due to COVID-19 pneumonia. Pt admitted from 11/11/22 to 11/15/22.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Electrocardiogram abnormal, Haemoglobin normal, Headache, Lung opacity, Metabolic function test normal
Clinical narrative: Narrative:  Patient called the Clinical Call Center to report he is on his 4th day of cough and congestion. Patient reports having severe shortness of breath with cough frequently. Patient reports productive cough with green sputum x 4 days, temperature normal but cannot remember the exact number, sore throat, nasal congestion, and headache. He reports testing negative for COVID-19 with home kit yesterday. He states that he has been taking Mucinex, Nebulizer treatments, and hydrating well and nothing is helping. He denies sob at rest, confusion, cp, vision changes, body aches. Patient advised to report to ED for evaluation. In ED, O2 sats in the low 90s at one point. HR was up to 121, pt received Lopressor (IV, 5mg, x2) w/ subsequent HR in low 100s. WBC 11.8K, Hgb 16.8. CMP largely unremarkable. Troponin negative. BNP 191. Covid PCR positive. EKG: Heart rate 121, A. fib, no ST elevation or depressions, occasional PVCs noted. CTA chest showing no evidence of PE, there is evidence of thrombus in left atrium, groundglass opacities in bilateral lower lobes and right upper lobe, nonobstructive nephrolithiasis less than 1 cm. Patient started on heparin drip. Patient also given morphine, Zofran, ketorolac. He received 3 days of IV Ceftriaxone and was de-escalated to Augmentin 875 mg BID X 2 more days. The patient was also treated for acute respiratory failure due to acute bacterial pneumonia. The patient did not require supplemental oxygen. He did not require any further care due to COVID-19 pneumonia. Pt admitted from 11/11/22 to 11/15/22.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Nasal congestion, Nephrolithiasis, Oropharyngeal pain, Pneumonia bacterial, Productive cough
Clinical narrative: Narrative:  Patient called the Clinical Call Center to report he is on his 4th day of cough and congestion. Patient reports having severe shortness of breath with cough frequently. Patient reports productive cough with green sputum x 4 days, temperature normal but cannot remember the exact number, sore throat, nasal congestion, and headache. He reports testing negative for COVID-19 with home kit yesterday. He states that he has been taking Mucinex, Nebulizer treatments, and hydrating well and nothing is helping. He denies sob at rest, confusion, cp, vision changes, body aches. Patient advised to report to ED for evaluation. In ED, O2 sats in the low 90s at one point. HR was up to 121, pt received Lopressor (IV, 5mg, x2) w/ subsequent HR in low 100s. WBC 11.8K, Hgb 16.8. CMP largely unremarkable. Troponin negative. BNP 191. Covid PCR positive. EKG: Heart rate 121, A. fib, no ST elevation or depressions, occasional PVCs noted. CTA chest showing no evidence of PE, there is evidence of thrombus in left atrium, groundglass opacities in bilateral lower lobes and right upper lobe, nonobstructive nephrolithiasis less than 1 cm. Patient started on heparin drip. Patient also given morphine, Zofran, ketorolac. He received 3 days of IV Ceftriaxone and was de-escalated to Augmentin 875 mg BID X 2 more days. The patient was also treated for acute respiratory failure due to acute bacterial pneumonia. The patient did not require supplemental oxygen. He did not require any further care due to COVID-19 pneumonia. Pt admitted from 11/11/22 to 11/15/22.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory tract congestion, SARS-CoV-2 test positive, Sepsis, Sputum discoloured, Troponin normal
Clinical narrative: Narrative:  Patient called the Clinical Call Center to report he is on his 4th day of cough and congestion. Patient reports having severe shortness of breath with cough frequently. Patient reports productive cough with green sputum x 4 days, temperature normal but cannot remember the exact number, sore throat, nasal congestion, and headache. He reports testing negative for COVID-19 with home kit yesterday. He states that he has been taking Mucinex, Nebulizer treatments, and hydrating well and nothing is helping. He denies sob at rest, confusion, cp, vision changes, body aches. Patient advised to report to ED for evaluation. In ED, O2 sats in the low 90s at one point. HR was up to 121, pt received Lopressor (IV, 5mg, x2) w/ subsequent HR in low 100s. WBC 11.8K, Hgb 16.8. CMP largely unremarkable. Troponin negative. BNP 191. Covid PCR positive. EKG: Heart rate 121, A. fib, no ST elevation or depressions, occasional PVCs noted. CTA chest showing no evidence of PE, there is evidence of thrombus in left atrium, groundglass opacities in bilateral lower lobes and right upper lobe, nonobstructive nephrolithiasis less than 1 cm. Patient started on heparin drip. Patient also given morphine, Zofran, ketorolac. He received 3 days of IV Ceftriaxone and was de-escalated to Augmentin 875 mg BID X 2 more days. The patient was also treated for acute respiratory failure due to acute bacterial pneumonia. The patient did not require supplemental oxygen. He did not require any further care due to COVID-19 pneumonia. Pt admitted from 11/11/22 to 11/15/22.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Ventricular extrasystoles, White blood cell count increased
Clinical narrative: Narrative:  Patient called the Clinical Call Center to report he is on his 4th day of cough and congestion. Patient reports having severe shortness of breath with cough frequently. Patient reports productive cough with green sputum x 4 days, temperature normal but cannot remember the exact number, sore throat, nasal congestion, and headache. He reports testing negative for COVID-19 with home kit yesterday. He states that he has been taking Mucinex, Nebulizer treatments, and hydrating well and nothing is helping. He denies sob at rest, confusion, cp, vision changes, body aches. Patient advised to report to ED for evaluation. In ED, O2 sats in the low 90s at one point. HR was up to 121, pt received Lopressor (IV, 5mg, x2) w/ subsequent HR in low 100s. WBC 11.8K, Hgb 16.8. CMP largely unremarkable. Troponin negative. BNP 191. Covid PCR positive. EKG: Heart rate 121, A. fib, no ST elevation or depressions, occasional PVCs noted. CTA chest showing no evidence of PE, there is evidence of thrombus in left atrium, groundglass opacities in bilateral lower lobes and right upper lobe, nonobstructive nephrolithiasis less than 1 cm. Patient started on heparin drip. Patient also given morphine, Zofran, ketorolac. He received 3 days of IV Ceftriaxone and was de-escalated to Augmentin 875 mg BID X 2 more days. The patient was also treated for acute respiratory failure due to acute bacterial pneumonia. The patient did not require supplemental oxygen. He did not require any further care due to COVID-19 pneumonia. Pt admitted from 11/11/22 to 11/15/22.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Blood gases abnormal, Bronchospasm, Carbon dioxide increased, Cough
Clinical narrative: Narrative: 71-year-old male with a past medical history of COPD, remote history of asthma, CAD, hypertension, DM, presents emergency department today with shortness of breath. Patients States that since getting his COVD booster approximately 6 weeks ago he developed shortness of breath that persisted for the last 4 to 5 weeks. Over the last week his symptoms have markedly worsened with profound wheezing and difficult performing ADLS due to dyspnea when walking just a few feet. His symptoms improved at nighttime when he wears a CPAP machine but immediately returned after taking it off in the morning. He has been using his Spiriva and is prescribed Tessalon along with as needed albuterol which he is using multiple doses of the day. He is coughing up a small amount of dark brownish-yellowish sputum. And he noticed over the last day that his symptoms have worsened. He has mild lower extremely edema which he says is chronic. He endorses a cough which causes lower abdominal pain but no other chest pain or abdominal pain that he can describe. He denies any previous symptoms as severe as they are currently and denies recent fevers. chills, nausea, vomiting, dizziness, passing out, headache sick contacts active smoking or drug use. Patient does state he had recent work-up where he had angiogram that was unremarkable Audible wheezing on arrival. Improved markedly with BIPAP, nebulizer treatment x3, methylprednisolone, magnesium. Patient's work up today demonstrated hypercapnia with elevated CO2 consistent with acute on chronic CO2 retention. Repeat blood gas after treatment shows significant improvement. Patient now ambulating throughout the ED without significant desaturations or discomfort. Upon review of patient's history, it appears that the was started on increased dose of metoprolol in late September around the time of onset of symptoms. Given his history of childhood asthma and COPD this may have been trigger to his persistent bronchospasm since that time. I am recommending the following. Prednisone x4 more days (First dose given in the emergency department), albuterol as needed, inhaled steroid as previously prescribed, and transition of blood pressure medication for metoprolol and amlodipine to carvedilol if tolerated.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Dyspnoea exertional, Hypercapnia, Oedema, Oedema peripheral
Clinical narrative: Narrative: 71-year-old male with a past medical history of COPD, remote history of asthma, CAD, hypertension, DM, presents emergency department today with shortness of breath. Patients States that since getting his COVD booster approximately 6 weeks ago he developed shortness of breath that persisted for the last 4 to 5 weeks. Over the last week his symptoms have markedly worsened with profound wheezing and difficult performing ADLS due to dyspnea when walking just a few feet. His symptoms improved at nighttime when he wears a CPAP machine but immediately returned after taking it off in the morning. He has been using his Spiriva and is prescribed Tessalon along with as needed albuterol which he is using multiple doses of the day. He is coughing up a small amount of dark brownish-yellowish sputum. And he noticed over the last day that his symptoms have worsened. He has mild lower extremely edema which he says is chronic. He endorses a cough which causes lower abdominal pain but no other chest pain or abdominal pain that he can describe. He denies any previous symptoms as severe as they are currently and denies recent fevers. chills, nausea, vomiting, dizziness, passing out, headache sick contacts active smoking or drug use. Patient does state he had recent work-up where he had angiogram that was unremarkable Audible wheezing on arrival. Improved markedly with BIPAP, nebulizer treatment x3, methylprednisolone, magnesium. Patient's work up today demonstrated hypercapnia with elevated CO2 consistent with acute on chronic CO2 retention. Repeat blood gas after treatment shows significant improvement. Patient now ambulating throughout the ED without significant desaturations or discomfort. Upon review of patient's history, it appears that the was started on increased dose of metoprolol in late September around the time of onset of symptoms. Given his history of childhood asthma and COPD this may have been trigger to his persistent bronchospasm since that time. I am recommending the following. Prednisone x4 more days (First dose given in the emergency department), albuterol as needed, inhaled steroid as previously prescribed, and transition of blood pressure medication for metoprolol and amlodipine to carvedilol if tolerated.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Positive airway pressure therapy, Productive cough, Sputum discoloured, Wheezing
Clinical narrative: Narrative: 71-year-old male with a past medical history of COPD, remote history of asthma, CAD, hypertension, DM, presents emergency department today with shortness of breath. Patients States that since getting his COVD booster approximately 6 weeks ago he developed shortness of breath that persisted for the last 4 to 5 weeks. Over the last week his symptoms have markedly worsened with profound wheezing and difficult performing ADLS due to dyspnea when walking just a few feet. His symptoms improved at nighttime when he wears a CPAP machine but immediately returned after taking it off in the morning. He has been using his Spiriva and is prescribed Tessalon along with as needed albuterol which he is using multiple doses of the day. He is coughing up a small amount of dark brownish-yellowish sputum. And he noticed over the last day that his symptoms have worsened. He has mild lower extremely edema which he says is chronic. He endorses a cough which causes lower abdominal pain but no other chest pain or abdominal pain that he can describe. He denies any previous symptoms as severe as they are currently and denies recent fevers. chills, nausea, vomiting, dizziness, passing out, headache sick contacts active smoking or drug use. Patient does state he had recent work-up where he had angiogram that was unremarkable Audible wheezing on arrival. Improved markedly with BIPAP, nebulizer treatment x3, methylprednisolone, magnesium. Patient's work up today demonstrated hypercapnia with elevated CO2 consistent with acute on chronic CO2 retention. Repeat blood gas after treatment shows significant improvement. Patient now ambulating throughout the ED without significant desaturations or discomfort. Upon review of patient's history, it appears that the was started on increased dose of metoprolol in late September around the time of onset of symptoms. Given his history of childhood asthma and COPD this may have been trigger to his persistent bronchospasm since that time. I am recommending the following. Prednisone x4 more days (First dose given in the emergency department), albuterol as needed, inhaled steroid as previously prescribed, and transition of blood pressure medication for metoprolol and amlodipine to carvedilol if tolerated.
Age: 76.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, COVID-19, Cough, Gait disturbance, Oropharyngeal pain
Clinical narrative: Narrative:  Pt who had received two doses of the Moderna Vaccine in 2021, reported to the ED on 11/15/2022 with sore throat, unsteady gait, cough, and weakness. Pt was admitted and further testing revealed positive covid-19 infection. Per provider notes no indication for remdesivir at this time supportive care only.
Age: 76.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative:  Pt who had received two doses of the Moderna Vaccine in 2021, reported to the ED on 11/15/2022 with sore throat, unsteady gait, cough, and weakness. Pt was admitted and further testing revealed positive covid-19 infection. Per provider notes no indication for remdesivir at this time supportive care only.
Age: 83.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute kidney injury, Asthenia, COVID-19, COVID-19 pneumonia, Cough
Clinical narrative: Narrative:  Patient received three COVID 19 Vaccine in Feb/Mar 2021 and Feb 2022. The patient tested positive for COVID 19 on 24 Sep 2022. The patient presented to the ED with generalized weakness, cough, sob with any activity, and black stool. The patient was admitted to the hospital with covid pneumonia and acute kidney injury. The patient was treated with oxygen and antibiotics. The patient was discharged on a 27 Sep 2022 in stable condition. Reported per EUA.
Age: 83.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dyspnoea, Faeces discoloured, SARS-CoV-2 test positive
Clinical narrative: Narrative:  Patient received three COVID 19 Vaccine in Feb/Mar 2021 and Feb 2022. The patient tested positive for COVID 19 on 24 Sep 2022. The patient presented to the ED with generalized weakness, cough, sob with any activity, and black stool. The patient was admitted to the hospital with covid pneumonia and acute kidney injury. The patient was treated with oxygen and antibiotics. The patient was discharged on a 27 Sep 2022 in stable condition. Reported per EUA.
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Anticoagulant therapy, Blood potassium increased, COVID-19, Complication associated with device, Faeces discoloured
Clinical narrative: Narrative:  MC, Moderna x4, outside covid test positive at nursing home. No covid symptoms. high potassium, blocked NG tube. GI bleed, on Eliquis, dark and blood stools. GI consult
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Gastrointestinal haemorrhage, Haematochezia, SARS-CoV-2 test positive
Clinical narrative: Narrative:  MC, Moderna x4, outside covid test positive at nursing home. No covid symptoms. high potassium, blocked NG tube. GI bleed, on Eliquis, dark and blood stools. GI consult
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, COVID-19, COVID-19 pneumonia, Cough, Dysarthria
Clinical narrative: Narrative:  Patient received Janssen COVID 10 vaccine in June 2021. The patient tested positive for COVID 19 on 6 Sep 2022. The patient presented to the ED with diaphoresis, nausea, cough, sob, believes speech became slurred. The patient was admitted with COVID pneumonia and acute kidney injury. The patient was treated with remdesivir and dexamethasone. The patient was discharged in stable condition with a referral for kidney function on 10 September 2022. Reported per EUA.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Hyperhidrosis, Nausea, SARS-CoV-2 test positive
Clinical narrative: Narrative:  Patient received Janssen COVID 10 vaccine in June 2021. The patient tested positive for COVID 19 on 6 Sep 2022. The patient presented to the ED with diaphoresis, nausea, cough, sob, believes speech became slurred. The patient was admitted with COVID pneumonia and acute kidney injury. The patient was treated with remdesivir and dexamethasone. The patient was discharged in stable condition with a referral for kidney function on 10 September 2022. Reported per EUA.
Age: 84.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, Cough, Dyspnoea, Hypoxia, Pneumonia aspiration
Clinical narrative: Narrative:  Patient received four doses COVID 19 vaccine in Jan/Feb/Apr/Oct 2021. The patient tested positive for COVID 19 on 24 Oct 2022. The patient presented to the ED with shortness of breath, cough, and fever. The patient was admitted with aspiration pneumonia, sepsis, and hypoxia. The patient was treated with antibiotics, oxygen, and steroids. The patient was discharged in stable condition on 4 Nov 2022. Reported per EUA.
Age: 84.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive, Sepsis
Clinical narrative: Narrative:  Patient received four doses COVID 19 vaccine in Jan/Feb/Apr/Oct 2021. The patient tested positive for COVID 19 on 24 Oct 2022. The patient presented to the ED with shortness of breath, cough, and fever. The patient was admitted with aspiration pneumonia, sepsis, and hypoxia. The patient was treated with antibiotics, oxygen, and steroids. The patient was discharged in stable condition on 4 Nov 2022. Reported per EUA.
Age: 79.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Bronchitis, COVID-19, Cough, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: Narrative:  Patient received four doses of COVID vaccine Jan x2 2021/Sep 2021/Apr 2022. The patient tested positive for COVID 19 on 20 Sep 2022. The patient presented to the ED on 20 Sep 2022 with shortness of breath, wheezing, and cough. The patient was admitted to the hospital with COVID 19 and bronchitis. The patient was treated with antibiotics, oxygen, inhalers, and steroids. The patient was discharged in stable condition on 23 Sep 2022. Reported per EUA.
Age: 79.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Wheezing
Clinical narrative: Narrative:  Patient received four doses of COVID vaccine Jan x2 2021/Sep 2021/Apr 2022. The patient tested positive for COVID 19 on 20 Sep 2022. The patient presented to the ED on 20 Sep 2022 with shortness of breath, wheezing, and cough. The patient was admitted to the hospital with COVID 19 and bronchitis. The patient was treated with antibiotics, oxygen, inhalers, and steroids. The patient was discharged in stable condition on 23 Sep 2022. Reported per EUA.
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19-2
Symptoms: COVID-19, Cough, Dyspnoea, SARS-CoV-2 test positive, Sepsis
Clinical narrative: Narrative:  Patient received COVID 19 vaccine in Mar/Apr 2021. The patient tested positive for COVID 19 on 9 Sep 2022. The patient presented to the ED with shortness of breath, and cough. The patient was admitted with sepsis and treated with remdesivir and steroids. The patient was discharged on 19 Sep 22 in stable condition. Reported per EUA.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19-2, COVID19-2
Symptoms: Acute kidney injury, Acute respiratory failure, COVID-19, COVID-19 pneumonia, Diarrhoea
Clinical narrative: Narrative: Patient received three doses of Pfizer COVID 19 vaccine Feb/Mar/Nov 2021. The patient tested positive for COVID 19 on 3 October 2022. Patient presented to ED at Medical Center with shortness of breath. The patient was admitted with COVID pneumonia, Acute Hypoxic Respiratory Failure, currently on 2L of O2. The patient was treated with remdesevir, ceftriaxone and Zithromax for possible bacterial pneumonia. The patient left against medical advice on 4 Oct 2022. The patient presented to the hospital on 8 October 2022 with shortness of breath and diarrhea. The patient was admitted with COVID pneumonia and hypoxia. The patient was treated with supportive treatment, dexamethasone and oxygen. The patient was discharged on 12 Oct 2022 on dexamethasone and oxygen. The patient was re-admitted on 21 October with respiratory depression and acute kidney injury. The patient was discharged on prednisone and oxygen on 29 October 2022. Reported per EUA.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19-2, COVID19-2
Symptoms: Dyspnoea, Hypoxia, Respiratory depression, SARS-CoV-2 test positive
Clinical narrative: Narrative: Patient received three doses of Pfizer COVID 19 vaccine Feb/Mar/Nov 2021. The patient tested positive for COVID 19 on 3 October 2022. Patient presented to ED at Medical Center with shortness of breath. The patient was admitted with COVID pneumonia, Acute Hypoxic Respiratory Failure, currently on 2L of O2. The patient was treated with remdesevir, ceftriaxone and Zithromax for possible bacterial pneumonia. The patient left against medical advice on 4 Oct 2022. The patient presented to the hospital on 8 October 2022 with shortness of breath and diarrhea. The patient was admitted with COVID pneumonia and hypoxia. The patient was treated with supportive treatment, dexamethasone and oxygen. The patient was discharged on 12 Oct 2022 on dexamethasone and oxygen. The patient was re-admitted on 21 October with respiratory depression and acute kidney injury. The patient was discharged on prednisone and oxygen on 29 October 2022. Reported per EUA.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Narrative: Patient complained of rash after receiving  the 2nd COVID 19 Vaccine.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Disability, Dyspnoea, Fatigue, Pain
Clinical narrative: Narrative:  8/13/2022 - Patient called and reported the following: Patient reports he had an adverse effect to the Moderna booster that he obtained 3 weeks ago. Patient reports he had shortness of breath, pounding heart, fatigue, joint pain, body aches, and swelling. Patient states he is not having symptoms now. Patient state he just wanted to report it. Patient reports being incapacitated from 7/22/22 - 8/4/22 d/t reactions from the COVID vaccine. Patient did not identify any treatment.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Palpitations, Swelling
Clinical narrative: Narrative:  8/13/2022 - Patient called and reported the following: Patient reports he had an adverse effect to the Moderna booster that he obtained 3 weeks ago. Patient reports he had shortness of breath, pounding heart, fatigue, joint pain, body aches, and swelling. Patient states he is not having symptoms now. Patient state he just wanted to report it. Patient reports being incapacitated from 7/22/22 - 8/4/22 d/t reactions from the COVID vaccine. Patient did not identify any treatment.
Age: 69.0
Sex: F
Vaccine: FLU4
Symptoms: Wrong product administered
Clinical narrative: PATIENT RECIEVED REGULAR FLU VACCINE INSTEAD OF HIGH DOSE
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Myocardial infarction
Clinical narrative: Narrative:  pt died on 10/18/2022 from HEART ATTACK (MYOCARDIAL INFARCTION) at home. Pt had the following past medical history in chart: N40.1 Benign prostatic hyperplasia (SCT 266569009) N52.8 Erectile dysfunction (SCT 860914002) F14.10 Cocaine abuse (SCT 78267003) 786.2 Cough (ICD-9-CM 786.2) 356.9 Unspecified idiopathic peripheral neuropathy (ICD-9-CM 356.9) I10. Benign essential hypertension (SCT 1201005) 272.4 Hyperlipidemia (ICD-9-CM 272.4) E11.65 DM - Diabetes mellitus (SCT 73211009) B18.2 Chronic hepatitis C (SCT 128302006) Pt had received a covid-19 EUA (J&J) vaccine on 8/20/2021. It appears this death is NOT RELATED TO THE COVID VACCINE given the long length of time between the date vaccine was given & the date of pt's death.
Age: 70.0
Sex: M
Vaccine: FLUX
Symptoms: Unevaluable event
Clinical narrative: Narrative: Severity listed as 'severe' by provider - history of Guillain Barre Syndrome. Historical, entered 8/26/22.
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Reaction to previous exposure to any vaccine
Clinical narrative: Narrative
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Flushing, Pharyngeal swelling, Sensation of foreign body
Clinical narrative: Narrative: Patient received her bivalent boost on 11/18/2022 and within 5 minutes  she reported that her throat was swelling, and she felt like she had a lump in her throat. Patient declined having an allergic reaction to vaccine prior to receiving  this. She was administered 25 mg IM diphenhydramine x2 doses. Patient declined  an epi-pen. Patient received the moderna monovalent booster on 6/15/22 and had  a similar reaction of a lump in her throat and feeling flushed. An allergy was not recorded at that time. Recorded allergy in patient's chart on 11/18/22.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Foaming at mouth
Clinical narrative: Narrative:  Pt was an 80 y/o male with a PMH of St. Jude valve replacement in 1991, CVA 1998, atrial fibrillation, COPD with chronic hypoxic respiratory failure on 2L of oxygen, Hypothyroidism, dementia, BPH, right hemiparesis, major depressive disorder, PTSD, and seizure disorder who presented to hospital from 6/26/2022-7/7/2022 admitted for falls and weakness. CT head negative and UA on admission w/o signs of infection (6/26/22). Started on vancomycin, cefepime, and flagyl in the ED for possible pulmonary infection given elevated WBC. CXR negative, procalcitonin negative and WBC normalized so abx were stopped. Patient then presented to hospital on 7/13/2022 for neurology visit. Patient being evaluated for tremors, progressive memory problems, and balance issues. Per neurology, patient has mild neurocognitive impairment which is multifactorial in nature. polypharmacy has been described as a concern, but patient refused to make medication changes at visit. Of note, patient has 3 family members who died from covid recently. Patient received his COVID-19 vaccination on 7/13/2022. Patient was given vaccine information sheet listing the risks, benefits and side effects of vaccination. Patient reviewed the information and gave verbal consent to receive the vaccine. He received the Pfizer COVID-19 vaccine in the right deltoid. Vaccine was administered without complications and patient was observed for 15 minutes after vaccination. Patient was found on Thursday morning 7/14/2022 deceased in his sleep, appeared comfortable, some foaming at the mouth was noted.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  patient had received a covid-19 EUA vaccine (J&J) from facility. Pt died on Nov 19,2022@00:01 per phone call to the facility from son, location of death UNKNOWN. Pt was in Home Based Primary Care. No information in chart regarding cause of pt's death. Primary Care Provider: Pt with the following Problem list: OSA with CPAP COPD HLD DMII HTN Tobacco use Obesity Chronic low back pain ED Benign neoplasm of colon Edema Hx of B12 deficiency, vitamin D deficiency Edentulous Toe wound-resolved Constipation Appears this patient's death IS NOT RELATED TO THE COVID VACCINE given long length of time between date of death & date EUA vaccine was given.
Age: 81.0
Sex: M
Vaccine: COVID19-2
Symptoms: Acute kidney injury, Asthenia, Bacterial test positive, Blood creatinine increased, Blood sodium decreased
Clinical narrative: Narrative: -Pt's son called the facility call center to report patient tested positive for COVID on 11/13/22. Son reported patient has become confused x 5 days, esp. when temp. is up. Pt has poor appetite. Patient triaged for ER. -Patient presented to facility ED on 11/23/2022. Patient c/o "COVID I think", patient c/o confusion x 3 weeks. Patient denies any N/V, pain, urinary s/s, patient denies any other symptoms besides "I'm incoherent", it all started when I got my flu shot. Patients son states he isn't eating like normal, low pulse ox at home 89% in bed, temp 101.3 last night at 0230. Pt has been taking Tylenol 1000mg. Son reports father has not felt well since 11/13. Father has felt weak, had poor appetite, feels confused at times, and stools have been loose. (NO vomiting, chest pain, or SOB). Pt wears a condom cath d/t urinary incontinence and urine has been dark - no dysuria. -Pt hospitalized at facility from 11/23 to 12/1 with PRINCIPAL DIAGNOSIS (Reason for admission after study): Covid 19 Infection Urinary Tract Infection due to ESBL + E Coli Chronic Condom Catheter Use AKI on CKD stage III RUL Opacity - suspected due to Covid 19 Infection -HOSPITAL COURSE: Pt was admitted to hospitalist service. He was started on IV ceftriaxone and IV fluids at time of admission. He did not require any supplemental oxygen so only supportive care was provided for Covid 19 infection. His renal function improved with IV fluids and discontinuation of HCTZ and lisinopril. His urine culture grew out two species of E Coli both of which were ESBL positive so antibiotics changed to IV Ertapenem which he received for 4 days. He will be discharged on oral Bactrim for 6 more days to complete 10 day course for complicated UTI.
Age: 81.0
Sex: M
Vaccine: COVID19-2
Symptoms: Body temperature increased, COVID-19, Chest X-ray abnormal, Chromaturia, Chronic kidney disease
Clinical narrative: Narrative: -Pt's son called the facility call center to report patient tested positive for COVID on 11/13/22. Son reported patient has become confused x 5 days, esp. when temp. is up. Pt has poor appetite. Patient triaged for ER. -Patient presented to facility ED on 11/23/2022. Patient c/o "COVID I think", patient c/o confusion x 3 weeks. Patient denies any N/V, pain, urinary s/s, patient denies any other symptoms besides "I'm incoherent", it all started when I got my flu shot. Patients son states he isn't eating like normal, low pulse ox at home 89% in bed, temp 101.3 last night at 0230. Pt has been taking Tylenol 1000mg. Son reports father has not felt well since 11/13. Father has felt weak, had poor appetite, feels confused at times, and stools have been loose. (NO vomiting, chest pain, or SOB). Pt wears a condom cath d/t urinary incontinence and urine has been dark - no dysuria. -Pt hospitalized at facility from 11/23 to 12/1 with PRINCIPAL DIAGNOSIS (Reason for admission after study): Covid 19 Infection Urinary Tract Infection due to ESBL + E Coli Chronic Condom Catheter Use AKI on CKD stage III RUL Opacity - suspected due to Covid 19 Infection -HOSPITAL COURSE: Pt was admitted to hospitalist service. He was started on IV ceftriaxone and IV fluids at time of admission. He did not require any supplemental oxygen so only supportive care was provided for Covid 19 infection. His renal function improved with IV fluids and discontinuation of HCTZ and lisinopril. His urine culture grew out two species of E Coli both of which were ESBL positive so antibiotics changed to IV Ertapenem which he received for 4 days. He will be discharged on oral Bactrim for 6 more days to complete 10 day course for complicated UTI.
Age: 81.0
Sex: M
Vaccine: COVID19-2
Symptoms: Condom catheter placement, Confusional state, Culture urine positive, Decreased appetite, Diarrhoea
Clinical narrative: Narrative: -Pt's son called the facility call center to report patient tested positive for COVID on 11/13/22. Son reported patient has become confused x 5 days, esp. when temp. is up. Pt has poor appetite. Patient triaged for ER. -Patient presented to facility ED on 11/23/2022. Patient c/o "COVID I think", patient c/o confusion x 3 weeks. Patient denies any N/V, pain, urinary s/s, patient denies any other symptoms besides "I'm incoherent", it all started when I got my flu shot. Patients son states he isn't eating like normal, low pulse ox at home 89% in bed, temp 101.3 last night at 0230. Pt has been taking Tylenol 1000mg. Son reports father has not felt well since 11/13. Father has felt weak, had poor appetite, feels confused at times, and stools have been loose. (NO vomiting, chest pain, or SOB). Pt wears a condom cath d/t urinary incontinence and urine has been dark - no dysuria. -Pt hospitalized at facility from 11/23 to 12/1 with PRINCIPAL DIAGNOSIS (Reason for admission after study): Covid 19 Infection Urinary Tract Infection due to ESBL + E Coli Chronic Condom Catheter Use AKI on CKD stage III RUL Opacity - suspected due to Covid 19 Infection -HOSPITAL COURSE: Pt was admitted to hospitalist service. He was started on IV ceftriaxone and IV fluids at time of admission. He did not require any supplemental oxygen so only supportive care was provided for Covid 19 infection. His renal function improved with IV fluids and discontinuation of HCTZ and lisinopril. His urine culture grew out two species of E Coli both of which were ESBL positive so antibiotics changed to IV Ertapenem which he received for 4 days. He will be discharged on oral Bactrim for 6 more days to complete 10 day course for complicated UTI.
Age: 81.0
Sex: M
Vaccine: COVID19-2
Symptoms: Escherichia infection, Haemoglobin decreased, Incoherent, Lung opacity, Malaise
Clinical narrative: Narrative: -Pt's son called the facility call center to report patient tested positive for COVID on 11/13/22. Son reported patient has become confused x 5 days, esp. when temp. is up. Pt has poor appetite. Patient triaged for ER. -Patient presented to facility ED on 11/23/2022. Patient c/o "COVID I think", patient c/o confusion x 3 weeks. Patient denies any N/V, pain, urinary s/s, patient denies any other symptoms besides "I'm incoherent", it all started when I got my flu shot. Patients son states he isn't eating like normal, low pulse ox at home 89% in bed, temp 101.3 last night at 0230. Pt has been taking Tylenol 1000mg. Son reports father has not felt well since 11/13. Father has felt weak, had poor appetite, feels confused at times, and stools have been loose. (NO vomiting, chest pain, or SOB). Pt wears a condom cath d/t urinary incontinence and urine has been dark - no dysuria. -Pt hospitalized at facility from 11/23 to 12/1 with PRINCIPAL DIAGNOSIS (Reason for admission after study): Covid 19 Infection Urinary Tract Infection due to ESBL + E Coli Chronic Condom Catheter Use AKI on CKD stage III RUL Opacity - suspected due to Covid 19 Infection -HOSPITAL COURSE: Pt was admitted to hospitalist service. He was started on IV ceftriaxone and IV fluids at time of admission. He did not require any supplemental oxygen so only supportive care was provided for Covid 19 infection. His renal function improved with IV fluids and discontinuation of HCTZ and lisinopril. His urine culture grew out two species of E Coli both of which were ESBL positive so antibiotics changed to IV Ertapenem which he received for 4 days. He will be discharged on oral Bactrim for 6 more days to complete 10 day course for complicated UTI.
Age: 81.0
Sex: M
Vaccine: COVID19-2
Symptoms: Pathogen resistance, SARS-CoV-2 test positive, Urinary incontinence, Urinary sediment present, Urinary tract infection
Clinical narrative: Narrative: -Pt's son called the facility call center to report patient tested positive for COVID on 11/13/22. Son reported patient has become confused x 5 days, esp. when temp. is up. Pt has poor appetite. Patient triaged for ER. -Patient presented to facility ED on 11/23/2022. Patient c/o "COVID I think", patient c/o confusion x 3 weeks. Patient denies any N/V, pain, urinary s/s, patient denies any other symptoms besides "I'm incoherent", it all started when I got my flu shot. Patients son states he isn't eating like normal, low pulse ox at home 89% in bed, temp 101.3 last night at 0230. Pt has been taking Tylenol 1000mg. Son reports father has not felt well since 11/13. Father has felt weak, had poor appetite, feels confused at times, and stools have been loose. (NO vomiting, chest pain, or SOB). Pt wears a condom cath d/t urinary incontinence and urine has been dark - no dysuria. -Pt hospitalized at facility from 11/23 to 12/1 with PRINCIPAL DIAGNOSIS (Reason for admission after study): Covid 19 Infection Urinary Tract Infection due to ESBL + E Coli Chronic Condom Catheter Use AKI on CKD stage III RUL Opacity - suspected due to Covid 19 Infection -HOSPITAL COURSE: Pt was admitted to hospitalist service. He was started on IV ceftriaxone and IV fluids at time of admission. He did not require any supplemental oxygen so only supportive care was provided for Covid 19 infection. His renal function improved with IV fluids and discontinuation of HCTZ and lisinopril. His urine culture grew out two species of E Coli both of which were ESBL positive so antibiotics changed to IV Ertapenem which he received for 4 days. He will be discharged on oral Bactrim for 6 more days to complete 10 day course for complicated UTI.